Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-02T19:05:59.345Z.
Calculation as of: 2026-10-02T19:05:59.345Z.
Quote observation: 2026-10-02T19:05:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a42e17afc1a1b5c0c05c4bcc318afc1e85bdb01f5d7a677422ba224d703768eb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.49B
Operating Cash Flow Yield
N/A
TTM Avg
3.96%
3Y Avg
3.96%
5Y Avg
3.96%
Market Cap
$1.74B
Operating Cash Flow Yield
18.38%
TTM Avg
11.21%
3Y Avg
10.43%
5Y Avg
9.14%
Market Cap
$1.71B
Operating Cash Flow Yield
N/A
TTM Avg
9.83%
3Y Avg
9.83%
5Y Avg
9.83%
Market Cap
$2.72B
Operating Cash Flow Yield
5.37%
TTM Avg
4.82%
3Y Avg
2.97%
5Y Avg
2.97%
Market Cap
$1.01B
Operating Cash Flow Yield
25.97%
TTM Avg
24.44%
3Y Avg
20.41%
5Y Avg
14.90%
Market Cap
$470.35M
Operating Cash Flow Yield
4.69%
TTM Avg
5.11%
3Y Avg
4.22%
5Y Avg
4.06%
Market Cap
$459.30M
Operating Cash Flow Yield
6.42%
TTM Avg
6.72%
3Y Avg
7.00%
5Y Avg
5.83%
Market Cap
$389.98M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | N/A | 3.96% | 3.96% | 3.96% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 18.38% | 11.21% | 10.43% | 9.14% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | 9.83% | 9.83% | 9.83% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 5.37% | 4.82% | 2.97% | 2.97% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | 25.97% | 24.44% | 20.41% | 14.90% |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | 4.69% | 5.11% | 4.22% | 4.06% |
| NRC Health (NRC)vs › | $459.30M | 6.42% | 6.72% | 7.00% | 5.83% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
